{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:29:32Z","timestamp":1781123372944,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pathogenic\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      gene variants cause HSD10 mitochondrial disease (HSD10 MD), which results in a wide spectrum of symptoms ranging from mild to severe. Typical symptoms include intellectual disability, choreoathetosis, cardiomyopathy, neurodegeneration, and abnormal behavior. This study investigated a novel c.59\u00a0C\u2009&gt;\u2009T variant of the\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      gene and the clinical phenotypic features of HSD10 MD (neonatal form) patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We describe a Chinese boy 2 months and 12 days old with intellectual disability, metabolic acidosis, hyperlactatemia, hypoglycemia, cholestatic hepatitis and myocardial enzyme levels, slightly elevated 2-methyl-3-hydroxybutyric acid (2M3HBA) levels and early death. Although full-length sequencing of the mitochondrial genome was normal, whole-exome sequencing of the proband and his parents revealed a novel de novo hemizygous variant, c.59\u00a0C\u2009&gt;\u2009T (p.S20L), of the\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      gene. Molecular dynamics simulation analysis and protein structural analysis suggested that the c.59\u00a0C\u2009&gt;\u2009T (p.S20L) variant may disrupt the conformational stability of the protein. On the basis of the combined results of phenotypic analysis, molecular genetic analysis, protein structural analysis and molecular dynamics simulation analysis, this novel variant is currently considered a likely pathogenic variant. HSD10 MD (neonatal form) can lead to hepatic dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      HSD10 MD (neonatal form) can lead to hepatic dysfunction. The de novo c.59\u00a0C\u2009&gt;\u2009T\n                      <jats:italic>HSD17B10<\/jats:italic>\n                      variant suggested a neonatal form of the HSD10 mitochondrial disease phenotype in a patient 2 months and 12 days old, broadening the variant spectrum of\n                      <jats:italic>HSD17B10-<\/jats:italic>\n                      related disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03513-2","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:15:18Z","timestamp":1741320918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel c.59\u00a0C\u2009&gt;\u2009T variant of the HSD17B10 gene as a possible cause of the neonatal form of HSD10 mitochondrial disease with hepatic dysfunction: a case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-8062","authenticated-orcid":false,"given":"Tao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"1","key":"3513_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10545-011-9415-4","volume":"35","author":"J Zschocke","year":"2012","unstructured":"Zschocke J. HSD10 disease: clinical consequences of mutations in the HSD17B10 gene. J Inherit Metab Dis. 2012;35(1):81\u20139. https:\/\/doi.org\/10.1007\/s10545-011-9415-4.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"3513_CR2","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1203\/00006450-200012000-00025","volume":"48","author":"J Zschocke","year":"2000","unstructured":"Zschocke J, Ruiter JP, Brand J, Lindner M, Hoffmann GF, Wanders RJ, Mayatepek E. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res. 2000;48(6):852\u20135. https:\/\/doi.org\/10.1203\/00006450-200012000-00025.","journal-title":"Pediatr Res"},{"issue":"13","key":"3513_CR3","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/hmg\/ddu072","volume":"23","author":"AJ Deutschmann","year":"2014","unstructured":"Deutschmann AJ, Amberger A, Zavadil C, Steinbeisser H, Mayr JA, Feichtinger RG, et al. Mutation or knock-down of 17\u03b2\u2010hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts. Hum Mol Genet. 2014;23(13):3618\u201328. https:\/\/doi.org\/10.1093\/hmg\/ddu072.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"3513_CR4","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1074\/jbc.274.21.15014","volume":"274","author":"XY He","year":"1999","unstructured":"He XY, Merz G, Mehta P, Schulz H, Yang SY. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J Biol Chem. 1999;274(21):15014\u20139. https:\/\/doi.org\/10.1074\/jbc.274.21.15014.","journal-title":"J Biol Chem"},{"issue":"18","key":"3513_CR5","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1046\/j.0014-2956.2001.02421.2421.x","volume":"268","author":"XY He","year":"2001","unstructured":"He XY, Merz G, Yang YZ, Mehta P, Schulz H, Yang SY. Characterization and localization of human type10 17beta-hydroxysteroid dehydrogenase. Eur J Biochem. 2001;268(18):4899\u2013907. https:\/\/doi.org\/10.1046\/j.0014-2956.2001.02421.2421.x.","journal-title":"Eur J Biochem"},{"issue":"12","key":"3513_CR6","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1002\/mgg3.1000","volume":"7","author":"PJ Waters","year":"2019","unstructured":"Waters PJ, Lace B, Buhas D, Gravel S, Cyr D, Boucher RM, Bernard G, Levesque S, Maranda B. HSD10 mitochondrial disease: p.Leu122Val variant, mild clinical phenotype, and founder effect in french-canadian patients from Quebec. Mol Genet Genomic Med. 2019;7(12):e1000. https:\/\/doi.org\/10.1002\/mgg3.1000.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"3513_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/emmm.200900055","volume":"2","author":"K Rauschenberger","year":"2010","unstructured":"Rauschenberger K, Sch\u00f6ler K, Sass JO, Sauer S, Djuric Z, Rumig C, et al. A nonenzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival. EMBO Mol Med. 2010;2(2):51\u201362. https:\/\/doi.org\/10.1002\/emmm.200900055.","journal-title":"EMBO Mol Med"},{"key":"3513_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2014.12.005","volume":"21","author":"KC Chatfield","year":"2015","unstructured":"Chatfield KC, Coughlin CR, Nd, Friederich MW, Gallagher RC, Hesselberth JR, Ofman R, et al. Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing. Mitochondrion. 2015;21:1\u201310. https:\/\/doi.org\/10.1016\/j.mito.2014.12.005.","journal-title":"Mitochondrion"},{"issue":"10","key":"3513_CR9","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1093\/nar\/gkv408","volume":"43","author":"E Vilardo","year":"2015","unstructured":"Vilardo E, Rossmanith W. Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complex. Nucleic Acids Res. 2015;43(10):5112\u20139. https:\/\/doi.org\/10.1093\/nar\/gkv408.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"3513_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinbiochem.2008.10.006","volume":"42","author":"J Garcia-Villoria","year":"2009","unstructured":"Garcia-Villoria J, Navarro-Sastre A, Fons C, Perez-Cerda C, Baldellou A, Fuentes-Castello MA, et al. Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis. Clin Biochem. 2009;42(1\u20132):27\u201333. https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.10.006.","journal-title":"Clin Biochem"},{"key":"3513_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/8904_2016_570","volume":"32","author":"S Akagawa","year":"2017","unstructured":"Akagawa S, Fukao T, Akagawa Y, Sasai H, Kohdera U, Kino M, et al. Japanese male siblings with 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency (HSD10 disease) without neurological regression. JIMD Rep. 2017;32:81\u20135. https:\/\/doi.org\/10.1007\/8904_2016_570.","journal-title":"JIMD Rep"},{"issue":"1","key":"3513_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jmd2.12250","volume":"62","author":"J Upadia","year":"2021","unstructured":"Upadia J, Walano N, Noh GS, Liu J, Li Y, Deputy S, et al. HSD10 disease in a female: a case report and review of literature. JIMD Rep. 2021;62(1):35\u201343. https:\/\/doi.org\/10.1002\/jmd2.12250.","journal-title":"JIMD Rep"},{"key":"3513_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2091-14-17","volume":"14","author":"SY Yang","year":"2013","unstructured":"Yang SY, Dobkin C, He XY, Brown WT. Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter. BMC Biochem. 2013;14:17. https:\/\/doi.org\/10.1186\/1471-2091-14-17.","journal-title":"BMC Biochem"},{"issue":"7621","key":"3513_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.39339.610000.BE","volume":"335","author":"MD Goodyear","year":"2007","unstructured":"Goodyear MD, Krleza-Jeric K, Lemmens T, The\u2002Declaration\u2002of\u2002Helsinki. BMJ. 2007;335(7621):624\u20135. https:\/\/doi.org\/10.1136\/bmj.39339.610000.BE.","journal-title":"BMJ"},{"issue":"5","key":"3513_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"9","key":"3513_CR16","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1007\/s12035-020-01993-4","volume":"57","author":"H Yang","year":"2020","unstructured":"Yang H, Yin F, Gan S, Pan Z, Xiao T, Kessi M, et al. The study of genetic susceptibility and mitochondrial dysfunction in mesial temporal lobe epilepsy. Mol Neurobiol. 2020;57(9):3920\u201330. https:\/\/doi.org\/10.1007\/s12035-020-01993-4.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3513_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10545-011-9413-6","volume":"35","author":"E Glamuzina","year":"2012","unstructured":"Glamuzina E, Brown R, Hogarth K, Saunders D, Russell-Eggitt I, Pitt M, et al. Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2. J Inherit Metab Dis. 2012;35(3):459\u201367. https:\/\/doi.org\/10.1007\/s10545-011-9413-6.","journal-title":"J Inherit Metab Dis"},{"key":"3513_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajhg.2014.12.023","volume":"96","author":"G Brea-Calvo","year":"2015","unstructured":"Brea-Calvo G, Haack TB, Karall D, Ohtake A, Invernizzi F, Carrozzo R, et al. COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am J Hum Genet. 2015;96:309\u201317. https:\/\/doi.org\/10.1016\/j.ajhg.2014.12.023.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"3513_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.13054","volume":"287","author":"S Rahman","year":"2002","unstructured":"Rahman S. Mitochondrial disease in children. J Intern Med. 2002;287(6):609\u201333. https:\/\/doi.org\/10.1111\/joim.13054.","journal-title":"J Intern Med"},{"issue":"3","key":"3513_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1203\/01.pdr.0000176916.94328.cd","volume":"58","author":"C Perez-Cerda","year":"2005","unstructured":"Perez-Cerda C, Garc\u00eda-Villoria J, Ofman R, Sala PR, Merinero B, Ramos J, et al. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatr Res. 2005;58(3):488\u201391. https:\/\/doi.org\/10.1203\/01.pdr.0000176916.94328.cd.","journal-title":"Pediatr Res"},{"issue":"6","key":"3513_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s11011-017-0097-y","volume":"32","author":"L Su","year":"2017","unstructured":"Su L, Li X, Lin R, Sheng H, Feng Z, Liu L. Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene. Metab Brain Dis. 2017;32(6):2063\u201371. https:\/\/doi.org\/10.1007\/s11011-017-0097-y.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"3513_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1086\/511527","volume":"80","author":"C Lenski","year":"2007","unstructured":"Lenski C, Kooy RF, Reyniers E, Loessner D, Wanders RJ, Winnepenninckx B, et al. The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior. Am J Hum Genet. 2007;80(2):372\u20137. https:\/\/doi.org\/10.1086\/511527.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"3513_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ymgme.2003.11.013","volume":"81","author":"BT Poll-The","year":"2004","unstructured":"Poll-The BT, Wanders RJ, Ruiter JP, Ofman R, Majoie CB, Barth PG, et al. Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases. Mol Genet Metab. 2004;81(4):295\u20139. https:\/\/doi.org\/10.1016\/j.ymgme.2003.11.013.","journal-title":"Mol Genet Metab"},{"key":"3513_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/8904_2016_547","volume":"32","author":"A Richardson","year":"2017","unstructured":"Richardson A, Berry GT, Garganta C, Abbott MA. Hydroxysteroid 17-beta dehydrogenase type 10 disease in siblings. JIMD Rep. 2017;32:25\u201332. https:\/\/doi.org\/10.1007\/8904_2016_547.","journal-title":"JIMD Rep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03513-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03513-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03513-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:15:19Z","timestamp":1741320919000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03513-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03513-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3924486\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate This study was approved by the Medical Ethics Committee of the Hunan Children\u2019s Hospital, and written informed consents were signed by the parents of all patients before this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}